Skip to content
Journal

International Research Journal of Oncology

Published by SCIENCEDOMAIN international

Search within this journal

239

Articles indexed

48

2026 articles

239

Open access

13

Citations (indexed)

Publications by year

Articles (239)

Role of Immune Checkpoints (PD-1, PDL1 and CTLA-4) In Triple-Negative Breast Cancer and Therapeutic Implications

Lawrence John AJutor, Blessing Aitebiereme Iyoyojie, Kingsley Ugonna Ugoagwu, Orkaa Terungwa Samuel, Olufemi Adesola Adedayo, Daniel Temiloluwa Oyedemi, Daniel Ebubechi Obasi, Adegbesan Abiodun Christopher, Adewoyin Peter Bemigho & Christian Ajiri Adobor · International Research Journal of Oncology · 2025

Triple-negative breast cancer (TNBC) is one of the most prominent types of breast cancer. It is a very aggressive subtype that is characterized by the absence of certain receptors which are expected on the surface of tumor cells. Limited treatment options and a poor prognosis, hi...

Open access Research Article 10.9734/irjo/2025/v8i1170

A Rare Case Presentation of Adenoid Cystic Carcinoma of the Breast in a 36-Year-Old Fe-male

Aradhana Mohan, Geeta S Narayanan & Kiran Kumar BR · International Research Journal of Oncology · 2025

Background: Primary adenoid cystic carcinoma (ACC) of breast is rarely seen clinically. It is a special subtype of triple-negative breast cancer characterized by low expression of Ki-67, low malignant potential, slow progression and favourable prognosis. To date, treatment for th...

Open access Research Article 10.9734/irjo/2025/v8i1169

Harnessing AI for Personalized Nutrition in Enhancing Immunotherapy Outcomes: A Systematic Review

Syed Umer Hasan, Pakapon Rojanaphan, Jeremiah E. Ochepo & Amjad Ali · International Research Journal of Oncology · 2024

Immunotherapy has emerged as a transformative approach in cancer treatment, yet its efficacy is often limited by interpatient variability and immune resistance mechanisms. Recent advances suggest that nutritional status and dietary interventions can significantly influence the im...

Open access Research Article 10.9734/irjo/2024/v7i2168

Unveiling T-Cell Prolymphocytic Leukaemia: A Comprehensive Case Study on Diagnostic Markers and Challenges

Balasuriya B L T, Madusanke G G S, Fernando D C P, Kulasooriya G G P N & Kariyawasan C C · International Research Journal of Oncology · 2024

Background: T-PLL is a rare T cell Chronic Lymphoproliferative disorder (T-CLPD), representing about 2% of mature lymphocytic leukaemia in adults over age of 30 years, with a median diagnosis age of 65 years. It commonly presents with symptoms like hepatosplenomegaly, generalized...

Open access Research Article 10.9734/irjo/2024/v7i2167

The Role of Primary Healthcare Physicians in Early Detection and Continuity of Care for Cancer Patients: A Review

Jane Nkechi Nwafor, Taiwo A Falaiye, Olubukola Anike Kuye, Simbiat Quadri Eniola, Ehireme Anne Osarenkhoe-Ighodaro, Kelechi Ethelbert Oguzie, Okelue E. Okobi & Maurice Puomaaye Konta · International Research Journal of Oncology · 2024

Primary care plays a vital role in cancer patients' early detection, referral, and ongoing management. This systematic review explores how primary care providers (PCPs) facilitate early diagnosis, ensure continuity of care, and support patients throughout their cancer journey and...

Open access Research Article 10.9734/irjo/2024/v7i2165

Clinical Characteristics and Prognosis of Papillary Thyroid Carcinoma in Adolescent Patients: A Single Center Study

Fenny Halim, Slamet Isworo, Enny Rachmani, Teguh Suryanto, Fitri Amalia, Grestaliansa Indira & Muhammad Faiq Malik Al Hakim · International Research Journal of Oncology · 2024

Background and Objective: The management of Papillary Thyroid Carcinoma (PTC) is influenced by factors such as patient age and clinical characteristics. However, the clinical features of PTC in adolescents (ages 10-19) have not been widely studied. Adolescents may present unique...

Open access Research Article 10.9734/irjo/2024/v7i2166

Advances in Molecular Diagnosis and Personalized Treatment of Soft Tissue Sarcomas

Gamal Abdul Hamid, Fadhel Hariri & Mauro Luisetto · International Research Journal of Oncology · 2024

Soft tissue tumors are a diverse range of diagnostic entities including the majority of them benign in nature and behavior. Soft tissue sarcomas are uncommon tumors that represent 1% of all malignancies and are classified as malignant entities. The wide variety of tumor types and...

Open access Research Article

The Effect of Immunosuppression on Kaposi Sarcoma: A Case Series

Rita Nkiru Ajirenike, Amaewhule Mary Nnneda, Dasetima D. Altraide, Figilo Ibeinmo Moses, Amadi Ekechi Stella, Johnson Mine & Ogbu Christian. · International Research Journal of Oncology · 2024

Kaposi sarcoma (K.S) is a rare type of cancer with four clinical variants which has a link to Human Herpes Virus (HHV-8) in the etiology. Commonly seen are the acquired immunodeficiency syndrome (AIDS) -related variants. Kaposi Sarcoma occurring after solid-organ transplant is a...

Open access Research Article

Enhancing Cancer Care in Nigeria: Addressing Gaps and Opportunities in Teaching Hospitals

Samuel Chukwuemeka Okenwa, Lazarus Chukwuemeka Ejike, Ifunanya Genevieve Anunwa, Jane Chidera Nwachukwu, Wisdom Joe Igbokwe, Henry Chiagozie Igwenagu, Emmanuel Buchi Onyioha, Joel Chekwube Ugwuezea & Chika Augusta Ekweozor · International Research Journal of Oncology · 2024

Background: Cancer is currently a global health issue and has claimed the lives of many.  Cancer used to be a previously more prevalent in high-income countries, but at the moment, 75% of new cancer cases could be from low and middle income countries (LMIC). Healthcare workers pl...

Open access Research Article

Non-Surgical Treatment Modalities in Colorectal Cancer Management: The Oncology Perspective

Silpa Choday, Tim Yu, Anthony Yeung & Varun Vankeshwaram · International Research Journal of Oncology · 2024

Colorectal cancer (CRC) is the third most common cancer worldwide, remains a major cause of cancer-related morbidity and mortality globally. It has diverse treatment modalities including chemotherapy, immunotherapy, and targeted therapies. Chemotherapy remains a cornerstone of CR...

Open access Research Article